Thomson Medical (SGX:A50) narrowed its attributable loss to owners during the fiscal second half ended June 30 by 44% to SG$19.5 million from SG$34.7 million a year earlier, according to a Wednesday filing with the Singapore Exchange.
Loss per share came in at SG$0.00074 compared with SG$0.00131 in the year-ago period.
Revenue edge up 5.8% year over year to SG$207.0 million from SG$195.6 million.